Analyst Consensus ?
ConsensusBuy21 ratings
Bullish1990.5%
Neutral14.8%
Bearish14.7%
Vertiv Holdings Co · VRT · FY2026 Q2 · Calendar Q3 2026
Vertiv raises 2026 outlook as AI infrastructure demand accelerates
The supplied analysis supports the view that resilient AI infrastructure demand and earnings growth are strengthening Vertiv's operating trajectory. Evidence includes Q2 growth, margin expansion, a raised full-year outlook, accelerating sales cycles and continued investment in power and cooling; the main counterweights are execution, supply-chain, tariff and capital-spending risks.
Reported Before market openNYSEIndustrials
$93.53B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.52
Consensus $1.43
EPS surprise
+6.3%
Reported versus consensus
Reported revenue
$3.27B
Consensus $3.38B
Revenue surprise
-3.1%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-17.3%
Event window
SPY move
-1.5%
Same window
Abnormal move
-15.7%
Stock minus SPY
Volume
4.4×
Versus trailing sessions
Subsequent drift
+18.3%
Up to 20 sessions
VRTSPY benchmark
Ask FN2 about VRT FY2026 Q2
Transcript, numbers and history already loaded
Why did VRT fall 17.3% after beating EPS estimates in FY2026 Q2?What changed in VRT's guidance and outlook in FY2026 Q2?Give me the bull and bear case for VRT after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management maintained a confident tone but raised the full-year outlook again and described faster sales cycles across regions. The product roadmap also advanced through 800V DC power, near-zero-water cooling, expanded capacity and thermal acquisitions.
Guidance delta
Management raised full-year 2026 guidance, with the supplied analysis citing $14 billion of net sales, $6.70 of adjusted EPS and $2.5 billion of free cash flow.
Key takeaways
- Q2 growth and margin expansion were strong, with the supplied analysis citing 24% year-over-year revenue growth, 60% adjusted EPS growth and a 22.6% operating margin.
- Management highlighted accelerating sales cycles, a strong pipeline and growth across the Americas, APAC and EMEA.
- The investment case is increasingly tied to 800V DC power, high-density cooling, capacity expansion and recent thermal acquisitions.
Management priorities
- Expand global manufacturing capacity and upgrade chiller capacity.
- Advance 800V DC power architecture and near-zero-water cooling solutions.
- Integrate thermal acquisitions and pursue complementary additions to the power-to-thermal portfolio.
Follow VRT with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$242.94Current
$18Low
$298.43Average
$500High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Outperform | Outperform | Maintain | Oct 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 12, 2026 |
| GLJ Research | Sell | Sell | Maintain | Oct 9, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | May 21, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 20, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 15, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 15, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 24, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 23, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 14, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 9, 2025 |
| UBS | Buy | Buy | Maintain | Oct 23, 2025 |
| Roth Capital | Buy | Buy | Maintain | Oct 21, 2025 |
| Melius Research | Buy | Hold | Upgrade | Jul 8, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 14, 2023 |
| Vertical Research | Buy | Hold | Upgrade | Jun 9, 2023 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Oct 27, 2022 |
| Guggenheim | Buy | Buy | Maintain | Nov 12, 2020 |
Named analyst price targets
Upside is calculated against the persisted current price $242.94. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $330 | $209.56 | +35.8% | Oct 16, 2026 |
| BMO Capital | Analyst unavailable | $329 | $252.18 | +35.4% | Oct 4, 2026 |
| Wells Fargo | Stephen Tusa | $340 | $245.3 | +40.0% | Sep 24, 2026 |
| GLJ Research | Analyst unavailable | $381 | $275.17 | +56.8% | Aug 7, 2026 |
| Bernstein | Varun Govindaraj | $368 | $242.93 | +51.5% | Jul 31, 2026 |
| UBS | Amit Mehrotra | $370 | $228.56 | +52.3% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $320 | $233.42 | +31.7% | Jul 30, 2026 |
| RBC Capital | Analyst unavailable | $337 | $237.54 | +38.7% | Jul 30, 2026 |
| Oppenheimer | Noah Kaye | $325 | $237.53 | +33.8% | Jul 30, 2026 |
| Evercore ISI | Analyst unavailable | $375 | $228.96 | +54.4% | Jul 29, 2026 |
| Piper Sandler | Analyst unavailable | $375 | $233.92 | +54.4% | Jul 29, 2026 |
| KeyBanc | Analyst unavailable | $360 | $301.16 | +48.2% | Jul 23, 2026 |
| RBC Capital | Analyst unavailable | $418 | $294 | +72.1% | Jul 16, 2026 |
| Robert W. Baird | Luke Junk | $370 | $304.57 | +52.3% | Jul 15, 2026 |
| Bernstein | Analyst unavailable | $416 | $289.52 | +71.2% | Jun 9, 2026 |
| Roth Capital | Justin Clare | $355 | $328.36 | +46.1% | May 21, 2026 |
| Oppenheimer | Noah Kaye | $353 | $315.67 | +45.3% | May 21, 2026 |
| Mizuho Securities | Brett Linzey | $380 | $315.67 | +56.4% | May 21, 2026 |
| RBC Capital | Deane Dray | $435 | $364.5 | +79.1% | May 15, 2026 |
| Barclays | Analyst unavailable | $412 | $376.23 | +69.6% | May 15, 2026 |
| Loop Capital Markets | Analyst unavailable | $500 | $376.23 | +105.8% | May 14, 2026 |
| Evercore ISI | Analyst unavailable | $425 | $357.43 | +74.9% | May 12, 2026 |
| Morgan Stanley | Analyst unavailable | $350 | $323.7 | +44.1% | Apr 23, 2026 |
| Oppenheimer | Analyst unavailable | $330 | $323.86 | +35.8% | Apr 23, 2026 |
| Cowen & Co. | Analyst unavailable | $347 | $316.09 | +42.8% | Apr 23, 2026 |
| RBC Capital | Analyst unavailable | $356 | $317 | +46.5% | Apr 23, 2026 |
| Barclays | Analyst unavailable | $345 | $305.14 | +42.0% | Apr 23, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $308.21 | +44.1% | Apr 20, 2026 |
| Roth Capital | Analyst unavailable | $335 | $301.16 | +37.9% | Apr 16, 2026 |
| BNP Paribas | Analyst unavailable | $345 | $299.96 | +42.0% | Apr 14, 2026 |
| Morgan Stanley | Analyst unavailable | $285 | $238.08 | +17.3% | Feb 13, 2026 |
| Oppenheimer | Analyst unavailable | $270 | $253.99 | +11.1% | Feb 12, 2026 |
| Goldman Sachs | Mark Delaney | $277 | $252.86 | +14.0% | Feb 12, 2026 |
| Barclays | Julian Mitchell | $281 | $252.69 | +15.7% | Feb 12, 2026 |
| RBC Capital | Deane Dray | $266 | $251.72 | +9.5% | Feb 12, 2026 |
| Roth Capital | Analyst unavailable | $275 | $248.51 | +13.2% | Feb 12, 2026 |
| Mizuho Securities | Brett Linzey | $290 | $248.51 | +19.4% | Feb 12, 2026 |
| Deutsche Bank | Analyst unavailable | $281 | $248.51 | +15.7% | Feb 12, 2026 |
| Evercore ISI | Analyst unavailable | $280 | $245.22 | +15.3% | Feb 11, 2026 |
| RBC Capital | Analyst unavailable | $200 | $176.96 | -17.7% | Jan 15, 2026 |
| Barclays | Julian Mitchell | $200 | $162.01 | -17.7% | Jan 2, 2026 |
| Goldman Sachs | Analyst unavailable | $204 | $185.61 | -16.0% | Dec 9, 2025 |
| Barclays | Analyst unavailable | $181 | $178.88 | -25.5% | Dec 4, 2025 |
| Cowen & Co. | Michael Elias | $211 | $177.86 | -13.1% | Dec 1, 2025 |
| Cowen & Co. | Michael Elias | $210 | $183.43 | -13.6% | Oct 23, 2025 |
| RBC Capital | Analyst unavailable | $196 | $180.95 | -19.3% | Oct 23, 2025 |
| UBS | Analyst unavailable | $201 | $171.59 | -17.3% | Oct 23, 2025 |
| Oppenheimer | Analyst unavailable | $195 | $171.59 | -19.7% | Oct 23, 2025 |
| Morgan Stanley | Christopher Snyder | $200 | $180.74 | -17.7% | Oct 23, 2025 |
| Goldman Sachs | Analyst unavailable | $182 | $171.59 | -25.1% | Oct 23, 2025 |
| Barclays | Analyst unavailable | $170 | $171.59 | -30.0% | Oct 23, 2025 |
| Roth Capital | Analyst unavailable | $195 | $175.73 | -19.7% | Oct 21, 2025 |
| Mizuho Securities | Analyst unavailable | $198 | $177.82 | -18.5% | Oct 17, 2025 |
| Deutsche Bank | Nicole Deblase | $216 | $175.15 | -11.1% | Oct 15, 2025 |
| Oppenheimer | Noah Kaye | $190 | $179 | -21.8% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $145 | $150.86 | -40.3% | Oct 1, 2025 |
| Goldman Sachs | Analyst unavailable | $159 | $138.62 | -34.6% | Sep 29, 2025 |
| Oppenheimer | Noah Kaye | $151 | $145.6 | -37.8% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $128 | $144.17 | -47.3% | Jul 31, 2025 |
| Mizuho Securities | Brett Linzey | $150 | $124.21 | -38.3% | Jul 16, 2025 |
| Wolfe Research | Nigel Coe | $155 | $120.72 | -36.2% | Jul 10, 2025 |
| UBS | Amit Mehrotra | $155 | $71.46 | -36.2% | Nov 13, 2024 |
| Cowen & Co. | Lance Vitanza | $115 | $110.03 | -52.7% | Oct 24, 2024 |
| Mizuho Securities | Brett Linzey | $125 | $109.72 | -48.5% | Oct 24, 2024 |
| Oppenheimer | Noah Kaye | $121 | $108.36 | -50.2% | Oct 24, 2024 |
| Evercore ISI | Amit Daryanani | $135 | $108.36 | -44.4% | Oct 23, 2024 |
| Cowen & Co. | Michael Elias | $93 | $95.98 | -61.7% | Sep 23, 2024 |
| Bank of America Securities | Andrew Obin | $115 | $76.99 | -52.7% | Sep 3, 2024 |
| Mizuho Securities | Brett Linzey | $92 | $69.27 | -62.1% | Aug 7, 2024 |
| Evercore ISI | Amit Daryanani | $105 | $95.31 | -56.8% | Jun 14, 2024 |
| Oppenheimer | Noah Kaye | $98 | $84.57 | -59.7% | Apr 25, 2024 |
| Wolfe Research | Nigel Coe | $97 | $85.34 | -60.1% | Apr 8, 2024 |
| Oppenheimer | Noah Kaye | $96 | $80.69 | -60.5% | Apr 4, 2024 |
| Wolfe Research | Nigel Coe | $94 | $81.01 | -61.3% | Mar 28, 2024 |
| Evercore ISI | Amit Daryanani | $80 | $73.37 | -67.1% | Mar 13, 2024 |
| Citigroup | Analyst unavailable | $18 | $13.64 | -92.6% | Dec 9, 2022 |
| Cowen & Co. | Lance Vitanza | $20 | $14.79 | -91.8% | Oct 27, 2022 |
| Mizuho Securities | Brett Linzey | $10 | $11.9 | -95.9% | Oct 4, 2022 |
| Goldman Sachs | Analyst unavailable | $17 | $12.65 | -93.0% | Aug 4, 2022 |
| Deutsche Bank | Analyst unavailable | $15 | $8.46 | -93.8% | Jul 13, 2022 |
| Goldman Sachs | Analyst unavailable | $15 | $10.99 | -93.8% | Jun 1, 2022 |
Track every rating change on VRT the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationVertiv Holdings Co, headquartered in Columbus, Ohio, is a global provider of essential digital infrastructure technologies and comprehensive lifecycle services. The company specializes in the design, manufacturing, and servicing of critical systems vital for data centers, communication networks, and diverse commercial and industrial applications. Its extensive product range encompasses AC and DC power management, thermal control solutions, integrated rack systems, modular designs, and sophisticated management platforms for monitoring and governing digital environments. These solutions are fundamental to the operation of numerous modern services, including e-commerce, online banking, file sharing, video on-demand, energy storage, wireless communications, the Internet of Things, and online gaming.…
Historical context
All VRT earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| LII Lennox International Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -10.6% | Lennox cuts outlook as pricing and tariffs pressure margins |
| IEX IDEX Corporation | FY2026 Q3 · Calendar Q4 2026 | — | +2.3% | IDEX raises 2026 outlook as advantage-market demand stays strong |
| CHRW C.H. Robinson Worldwide, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -11.1% | C.H. Robinson: Lean AI, RXO and Margin Expansion |
| CR Crane Company | FY2026 Q3 · Calendar Q4 2026 | +12.6% | +2.9% | Crane posts record Q3 and raises full-year EPS guidance |
| CLH Clean Harbors, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +0.1% | Clean Harbors raises 2026 EBITDA outlook after record Q3 |
| FER Ferrovial N.V. | FY2026 Q3 · Calendar Q4 2026 | — | +7.3% | Ferrovial: Core infrastructure growth and new U.S. awards stand out |
Latest beats and misses
Who reports nextBeat on EPS
- TMUSFY2026 Q3 · October 28, 2026+11.4% EPS+0.9% move
- AVTRFY2026 Q3 · October 28, 2026+5.3% EPS-2.6% move
- DBFY2026 Q3 · October 28, 2026+18.2% EPS+4.3% move
- FMXFY2026 Q2 · October 28, 2026+5.8% EPS-0.5% move
- EVRFY2026 Q3 · October 28, 2026+69.8% EPS+12.5% move
- EXEFY2026 Q3 · October 27, 2026+13.2% EPS-3.2% move
Missed on EPS
- UMCFY2026 Q3 · October 28, 2026-8.7% EPS-3.2% move
- EQNRFY2026 Q3 · October 28, 2026-13.0% EPS+1.3% move
- SWFY2026 Q3 · October 28, 2026-29.5% EPS-5.2% move
- UBSFY2026 Q3 · October 28, 2026-6.6% EPS-0.2% move
- WPCFY2026 Q3 · October 27, 2026-12.9% EPS-1.1% move
- WMFY2026 Q3 · October 27, 2026-1.4% EPS-3.2% move
Get the VRT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-05T17:14:05.594784+00:00
- FN2 earnings calendar · 2026-09-03T01:23:14.877038+00:00
- Polygon adjusted daily market bars · 2026-10-29T03:50:43.658165+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-29T03:50:43.655442+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-29. For educational purposes only; not investment advice.